 "vaccine")
India’s vaccine think-tank the National Technical Advisory Group on Immunisation (NTAGI) is likely to meet mid-week to review the data of Covid-19 vaccines Covovax and Corbevax for the age group 5-12 years, according to sources in the know.
This may pave the way for the inclusion of younger children in the national immunisation mission if the NTAGI finds the data satisfactory. A senior government official had told Business Standard last week that so far there was no scientific evidence to expand the vaccination programme to young children. “There are no plans yet to include children below 12 years in the vaccination
